Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.3931
+0.0025 (0.64%)
At close: Jul 24, 2026, 4:00 PM EDT
0.4183
+0.0252 (6.41%)
After-hours: Jul 24, 2026, 7:46 PM EDT
Vivos Therapeutics Stock Forecast
VVOS's stock price has decreased by -92.99% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Vivos Therapeutics stock has a consensus rating of "Buy" and an average price target of $2.12. The average 1-year stock price forecast is 439.30% higher than the current stock price, while the lowest is $0.75 (+90.79%) and the highest is $3.10 (+688.60%).
Price Target: $2.12 (+439.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vivos Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Hold Maintains $1.75 → $0.75 | Hold | Maintains | $1.75 → $0.75 | +90.79% | Jul 8, 2026 |
| Ascendiant | Ascendiant | Buy Reiterates $3 → $3.1 | Buy | Reiterates | $3 → $3.1 | +688.60% | Jun 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +535.97% | Apr 17, 2026 |
Financial Forecast
Revenue This Year
24.06M
from 17.44M
Increased by 37.91%
Revenue Next Year
34.09M
from 24.06M
Increased by 41.71%
EPS This Year
-1.39
from -2.07
EPS Next Year
-0.79
from -1.39
EPS and Forward PE are based on non-GAAP adjusted numbers.